Production of new flu vaccine each year shows it should be possible to adapt to coronavirus variants if necessary

The technology exists to rapidly tweak vaccines in the face of new coronavirus mutations. But it would take time, and a global strategy is needed to ensure that scientists stay one step ahead.

The emergence of more transmissible variants of Sars-CoV-2 has prompted debate over whether the vaccines developed to date will continue to give protection. Although there is little evidence to suggest this is an issue with the variants detected in the UK, South Africa and Brazil, immunologists fear further mutations.

Continue reading…

You May Also Like

Bernard Cribbins, star of Doctor Who and Jackanory, dies aged 93

The actor, comedian and singer had a career spanning eight decades from…

Ukraine talks: Russia sees no grounds for optimism ahead of Nato meeting

Moscow’s chief negotiator played down chances of a breakthrough as Russian troops…

‘To dive into yourself is scary’: the anxiety and awesome alt-rock of Liars

For 20 years, Angus Andrew has made Liars one of rock’s most…